Mavacamten is administered orally. Capsules are available in 2.5, 5, 10, and 15 mg doses. The recommended starting dose is 5 mg once a day. Dose titration might occur at weeks 4, 8, and 12 after treatment initiation. Maximal approved dose is 15 mg daily. Target plasma concentration for mavacamten ranges from 350 ng/mL to 700 ng/mL, and it might take weeks to reach steady-state levels and therapeutic effects.